Veradigm (NASDAQ:MDRX) Shares Gap Up – Should You Buy?

Veradigm Inc. (NASDAQ:MDRX)’s stock price gapped up prior to trading on Monday . The stock had previously closed at $4.26, but opened at $4.65. Veradigm shares last traded at $4.75, with a volume of 787 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Veradigm to a “hold” rating in a report on Saturday.

Veradigm Stock Up 9.2%

The company has a market capitalization of $506.39 million, a P/E ratio of 23.25 and a beta of 0.54. The firm has a fifty day simple moving average of $4.62 and a 200-day simple moving average of $4.72.

About Veradigm

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.